These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29427110)

  • 1. Animal Models of Machado-Joseph Disease.
    Schmidt J; Schmidt T
    Adv Exp Med Biol; 2018; 1049():289-308. PubMed ID: 29427110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.
    Cunha-Santos J; Duarte-Neves J; Carmona V; Guarente L; Pereira de Almeida L; Cavadas C
    Nat Commun; 2016 May; 7():11445. PubMed ID: 27165717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
    Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
    Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
    Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L
    Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Therapies for Machado-Joseph Disease.
    Duarte-Silva S; Maciel P
    Adv Exp Med Biol; 2018; 1049():369-394. PubMed ID: 29427114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
    Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
    Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
    Nóbrega C; Simões AT; Duarte-Neves J; Duarte S; Vasconcelos-Ferreira A; Cunha-Santos J; Pereira D; Santana M; Cavadas C; de Almeida LP
    Adv Exp Med Biol; 2018; 1049():349-367. PubMed ID: 29427113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
    Colomer Gould VF; Goti D; Pearce D; Gonzalez GA; Gao H; Bermudez de Leon M; Jenkins NA; Copeland NG; Ross CA; Brown DR
    Neurobiol Dis; 2007 Sep; 27(3):362-9. PubMed ID: 17632007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome.
    Braga-Neto P; Pedroso JL; Gadelha A; Laureano MR; de Souza Noto C; Garrido GJ; Barsottini OG
    Cerebellum; 2016 Aug; 15(4):483-90. PubMed ID: 26298474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.
    Simões AT; Gonçalves N; Nobre RJ; Duarte CB; Pereira de Almeida L
    Hum Mol Genet; 2014 Sep; 23(18):4932-44. PubMed ID: 24817574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease.
    Duarte-Neves J; Cavadas C; Pereira de Almeida L
    Sci Rep; 2021 Feb; 11(1):3345. PubMed ID: 33558582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
    Esteves S; Duarte-Silva S; Naia L; Neves-Carvalho A; Teixeira-Castro A; Rego AC; Silva-Fernandes A; Maciel P
    PLoS One; 2015; 10(10):e0141610. PubMed ID: 26505994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3.
    Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P
    FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of mitochondrial DNA damage in blood and brain tissues of a transgenic mouse model of Machado-Joseph disease.
    Kazachkova N; Raposo M; Montiel R; Cymbron T; Bettencourt C; Silva-Fernandes A; Silva S; Maciel P; Lima M
    Neurodegener Dis; 2013; 11(4):206-14. PubMed ID: 22832131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machado-Joseph shoe.
    Liu CS; Hsieh M; Chen YY; Lo MC
    Mov Disord; 2005 Jan; 20(1):66-8. PubMed ID: 15390034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.